This inventor holds 7 USPTO granted patents. Top assignees: Diagnostic Products Corporation, Reprogen, Inc., Siemens Healthcare Diagnostics Gmbh. Active years: 1998-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Los Angeles, CA (US) (1998)
- San Clemente, CA (US) (2001 - 2009)
Company Filing History:

Years Active: 1998-2009
Title: The Innovative Contributions of Karen K Yamamoto
Introduction
Karen K Yamamoto is a prominent inventor based in San Clemente, CA (US). She has made significant contributions to the field of medical diagnostics, particularly in prostate cancer research. With a total of 7 patents to her name, her work has had a profound impact on the diagnosis and treatment of this serious condition.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Method for following the progress of prostate cancer." This invention provides cDNA encoding a prostate-cancer specific marker, Repro-PC-1.0, along with Repro-PC-1.0 polypeptides and methods for use in diagnosis and therapy. Another notable patent is the "Prostate cancer-specific marker," which also focuses on cDNA encoding the same prostate-cancer specific marker, Repro-PC-1.0, and its applications in medical diagnostics.
Career Highlights
Throughout her career, Karen has worked with several notable companies, including Diagnostic Products Corporation and Reprogen, Inc. Her experience in these organizations has allowed her to develop innovative solutions that address critical health issues.
Collaborations
Karen has collaborated with esteemed colleagues such as Cynthia K French and Patrick A Schneider. These partnerships have further enhanced her research and development efforts in the field of cancer diagnostics.
Conclusion
Karen K Yamamoto's contributions to medical innovation, particularly in prostate cancer diagnostics, highlight her dedication and expertise in the field. Her patents and collaborations continue to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile